HIV/AIDS Clinical Care: Meetings

Continued Concern About Abacavir and Cardiovascular Risk

• HIV/AIDS Clinical Care
• Meeting Report
• Subscription Required

This year’s Retrovirus Conference did little to alleviate concerns about the previously published association between abacavir use and increased risk for cardiovascular disease.

• By Keith Henry, MD
• March 9, 2009

Treatment Is Preventive, but Some Risk Remains

• HIV/AIDS Clinical Care
• Meeting Report
• Subscription Required

In two observational studies presented at CROI 2009, the likelihood of HIV transmission in serodiscordant couples was much lower when infected partners were receiving ART than when they were not.

• By Carlos del Rio, MD
• March 9, 2009

When Should ART Be Initiated in Patients with OIs?

• HIV/AIDS Clinical Care
• Meeting Report
• Free Article

Data presented at the 2009 Retrovirus Conference bring us closer to a definitive answer.

• By Gerald H. Friedland, MD
• March 9, 2009

Concomitant HIV/TB Treatment Improves Survival

• HIV/AIDS Clinical Care
• Meeting Report
• Free Article

Delaying antiretroviral therapy until after TB treatment has been completed is associated with increased mortality risk.

• By Paul E. Sax, MD
• March 9, 2009

Report from the 10th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV

• HIV/AIDS Clinical Care
• Meeting Report
• Subscription Required

An expert’s take on the most clinically relevant findings presented at the conference

• By Judith Currier, MD, MSc
• December 8, 2008

Report from the 2008 Joint ICAAC/IDSA Meeting

• HIV/AIDS Clinical Care
• Meeting Report
• Free Article

The most important HIV-related findings from this year’s meeting

• November 10, 2008

Possible Strategies for Central Adiposity: Ritonavir-Boosted Atazanavir and Tesamorelin

• HIV/AIDS Clinical Care
• Meeting Report
• Subscription Required

Studies on these strategies were detailed at this year’s International AIDS Conference.

• By Paul E. Sax, MD
• September 15, 2008

New Agents: IDX899, RDEA806, and Apricitabine

• HIV/AIDS Clinical Care
• Meeting Report
• Subscription Required

Several new agents with high barriers to resistance were described at the 2008 International AIDS Conference.

• By Judith Feinberg, MD
• September 15, 2008

Progress Toward a Heat-Stable Ritonavir Tablet

• HIV/AIDS Clinical Care
• Meeting Report
• Subscription Required

The tablet under development is bioequivalent to the current soft gel-cap formulation, according to data presented at the 2008 International AIDS Conference.

• By Judith Feinberg, MD
• September 15, 2008

HIV Drug Resistance in Resource-Constrained Settings

• HIV/AIDS Clinical Care
• Meeting Report
• Subscription Required

Five to ten percent of treatment-naive patients in these settings have primary drug resistance, according to data presented at the 2008 International AIDS Conference.

• By Carlos del Rio, MD
• September 15, 2008